The chronic consumption of alcohol is known to be associated with the toxicity of numerous foreign compounds, including drugs, that undergo metabolic activation by cytochrome P-450. This laboratory purified and characterized the ethanol-inducible form of the cytochrome (termed P-450 isozyme 3a on the basis of eleccrophoretic behavior or P-450ALC to indicate high activity in alcohol oxygenation) and has since shown the central role of this catalyst in alcohol-related toxicities.
The specific aims of this proposal are: (a) to complete the characterization of various forms of P-450's involved in alcohol oxidation, including hepatic isozyme 3a, a non-inducible but immunochemically similar cytochrome in nasal membranes, and a variant nasal cytochrome having different electrophoretic behavior and much higher catalytic activities; (b) to determine the mechanism(s) by which diverse agents and treatments cause induction of P-450ALC; and (c) to determine whether the variable responses of different animals to the inducing effects of ethanol can be predicted. The purified enzymes will be sequenced and examined for post-translational modifications, and an attempt will be made to correlate substrate specificity with any structural differences found. Other organelles such as mitochondria and nuclei, and other tissues such as esophagus, stomach, aorta, endocrine tissues, and brain will be examined for interesting new forms of P-450ALC. Variants will also be identified by screening of an appropriate cDNA library. Determination of the level(s) of which P-450ALC biosynthesis is regulated will involve measurement of rates of transcription in isolated nuclei and quantitation of intranuclear precursors and cytoplasmic mRNA transcripts using cloned cDNA as a hybridization probe, as well as quantitation of cellular enzyme levels by radioimmunoassay. The P-450ALC genes will be identified and characterized by restriction mapping, Southern blotting, and sequence determination, and regulatory elements will be identified in the f'-flanking region or elsewhere. With an improved understanding of P-450ALC variants and of the control of P-450ALC gene expression in various tissues, attempts will be made to show by the techniques of molecular genetics whether an animal has been chronically exposed to ethanol and to predict whether a particular animal will be highly induced by such exposure.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
2R01AA006221-04
Application #
3109419
Study Section
Alcohol Biomedical Research Review Committee (ALCB)
Project Start
1983-12-01
Project End
1991-11-30
Budget Start
1986-12-01
Budget End
1987-11-30
Support Year
4
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Vatsis, Kostas P; Coon, Minor J (2005) Oxidative aldehyde deformylation catalyzed by NADPH-cytochrome P450 reductase and the flavoprotein domain of neuronal nitric oxide synthase. Biochem Biophys Res Commun 337:1107-11
Vatsis, Kostas P; Peng, Hwei-Ming; Coon, Minor J (2005) Abolition of oxygenase function, retention of NADPH oxidase activity, and emergence of peroxidase activity upon replacement of the axial cysteine-436 ligand by histidine in cytochrome P450 2B4. Arch Biochem Biophys 434:128-38
Vatsis, Kostas P; Peng, Hwei-Ming; Coon, Minor J (2002) Replacement of active-site cysteine-436 by serine converts cytochrome P450 2B4 into an NADPH oxidase with negligible monooxygenase activity. J Inorg Biochem 91:542-53
Peng, H M; Coon, M J (2000) Promoter function and the role of cytokines in the transcriptional regulation of rabbit CYP2E1 and CYP2E2. Arch Biochem Biophys 382:129-37
Vaz, A D; McGinnity, D F; Coon, M J (1998) Epoxidation of olefins by cytochrome P450: evidence from site-specific mutagenesis for hydroperoxo-iron as an electrophilic oxidant. Proc Natl Acad Sci U S A 95:3555-60
Coon, M J; Vaz, A D; McGinnity, D F et al. (1998) Multiple activated oxygen species in P450 catalysis: contributions To specificity in drug metabolism. Drug Metab Dispos 26:1190-3
Peng, H M; Coon, M J (1998) Regulation of rabbit cytochrome P450 2E1 expression in HepG2 cells by insulin and thyroid hormone. Mol Pharmacol 54:740-7
Jiang, Y; Kuo, C L; Pernecky, S J et al. (1998) The detection of cytochrome P450 2E1 and its catalytic activity in rat testis. Biochem Biophys Res Commun 246:578-83
Kuo, C L; Vaz, A D; Coon, M J (1997) Metabolic activation of trans-4-hydroxy-2-nonenal, a toxic product of membrane lipid peroxidation and inhibitor of P450 cytochromes. J Biol Chem 272:22611-6
Pernecky, S J; Coon, M J (1996) N-terminal modifications that alter P450 membrane targeting and function. Methods Enzymol 272:25-34

Showing the most recent 10 out of 44 publications